Buclorhex

Quick links to important sections

Buclorhex

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Buclorhex

Quick Facts

Property Description
Active ingredients Chlorhexidine Gluconate, Fluoride
Form Oral Rinse (Liquid formulation)
Pharmacological class Oral Antiseptic and Anti-Cariogenic Agent
Common use Specialized oral hygiene, plaque and gingivitis management
Origin Synthetic

What Type of Medicine and Formulation is Buclorhex?

Buclorhex is defined as a combination medicine and a topical antimicrobial agent, formulated as an oral rinse for topical administration within the mouth. This product is classified within the pharmacological class of oral antiseptics and anti-cariogenic agents. The combination of Chlorhexidine Gluconate and Fluoride is a distinctive feature of Buclorhex, differentiating it from single-ingredient rinses by addressing both microorganism control and tooth structure integrity in one liquid formulation.

What are the Active Ingredients in Buclorhex?

The composition of Buclorhex contains two active ingredients: Chlorhexidine Gluconate (CHG) and Fluoride. Chlorhexidine Gluconate is a broad-spectrum antimicrobial biguanide used as an antiseptic for dental conditions. Fluoride, often present as Sodium Fluoride, is essential for its anti-cariogenic function. The pairing of these two agents is clinically recognized for providing comprehensive support for oral health in patients requiring more than basic oral hygiene.

What is the General Purpose of Buclorhex?

The general purpose of Buclorhex is to support specialized oral hygiene by managing bacterial load and reinforcing tooth structure. It is intended to help control the formation of dental plaque and address gum infections like gingivitis. A systematic review confirmed that Chlorhexidine mouthwashes provide superior reduction in plaque and gingivitis compared to placebo. Furthermore, Fluoride promotes enamel remineralization, which is critical for preventing dental caries. This synergistic mechanism principle makes Buclorhex a targeted topical tool for achieving better long-term dental health.

What side effects are possible with Buclorhex?

Possible Side Effects and Safety Information

The safety profile of Buclorhex, an oral rinse containing Chlorhexidine Gluconate and Fluoride, is based strictly on classifications found in official government regulatory documents. The documented adverse reactions are primarily local and related to the topical administration of the antiseptic component.


Frequency-Classified Adverse Reactions

Adverse reactions are categorized by frequency of occurrence, as defined in regulatory labeling:

  • Common Reactions (affecting up to 1 in 10 people): Include taste disturbance (dysgeusia), temporary staining of the teeth and tongue, and an increase in calculus (tartar) formation.
  • Uncommon Reactions (affecting up to 1 in 100 people): Documented reports of dryness of the mouth (xerostomia).
  • Rare Reactions (affecting up to 1 in 1,000 people): May include parotid gland swelling.
  • Very Rare Reactions (affecting up to 1 in 10,000 people): The most serious documented concern is the potential for anaphylaxis, a severe, life-threatening systemic allergic reaction.

Safety Considerations and Constraints

The documented safety profile emphasizes two key areas. First, the occurrence of staining is noted in official documents to increase with the duration of use or long-term exposure to the rinse. Second, the official labeling imposes strict constraints: the product is for oral use only and must not be swallowed (ingested). Furthermore, use is contraindicated in individuals with known hypersensitivity to Chlorhexidine Gluconate or any other ingredient in the formulation. These elements structure the regulatory understanding of risk, defining the product as a local treatment with primary side effects confined to the application site.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Buclorhex overdose pertains to the clinical effects and management of accidental oral ingestion of the liquid formulation.

Documented Overdose Manifestations

Acute ingestion is officially documented to present with gastrointestinal symptoms including nausea, vomiting, and abdominal pain. Localized mucosal irritation and excessive salivation have also been reported. In cases of significant systemic exposure, there is documentation of transient liver enzyme elevation.

Severe Outcomes and Required Actions

Massive acute ingestion presents a risk of severe, officially documented outcomes. These include hypotension and CNS depression from the antiseptic component, and hypocalcemia and potentially cardiac arrhythmias or convulsions from the fluoride component. Pediatric considerations are noted due to the increased risk and potential for greater severity in children.

Regulatory guidance mandates that individuals seek immediate medical attention upon suspected ingestion of the oral rinse. Emergency services should be contacted immediately if severe systemic signs are observed.

Official Management and Monitoring

Treatment is defined as primarily symptomatic and supportive. The regulatory label states that no specific antidote is known for the antiseptic ingredient. Management protocols describe the use of gastric lavage or activated charcoal in large ingestion cases, and calcium administration is a specific required procedural step to counteract fluoride-induced hypocalcemia. Hospital monitoring is required following significant ingestion to observe electrolyte status and cardiac function.

Therapeutic Uses of Buclorhex

What Buclorhex Treats: Main Uses and Benefits

Buclorhex is relevant in contexts involving inflammatory or irritative states, where symptomatic support is needed to manage discomfort and related manifestations. It is commonly used in areas where short-term symptom management is appropriate. The active antiseptic agent is used to treat gingivitis, a condition characterized by gum inflammation.

The medication may be part of symptomatic management across conditions presenting with episodic or fluctuating symptom patterns. It is primarily used for managing acute gum inflammation, supporting post-dental healing, and addressing hygiene challenges when symptoms interfere with daily functioning. By providing supportive relief, the medication contributes to easing the overall symptom load.

“The symptomatic relief may assist with maintaining a sense of stability when symptoms are more noticeable, supporting the patient during difficult episodes by easing distress.”


Quick Fact: Support for Inflammatory or Irritative States

The supportive relief offered is considered relevant for managing symptoms that interfere with daily comfort, and may assist with maintaining functional stability during symptomatic periods, particularly after minor dental work.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Buclorhex? — Official Regulatory Information


Eligibility Scope

Populations for whom use is allowed (as stated in label):

  • Patients with gingivitis, characterized by redness, swelling, and bleeding of the gingivae.

Populations for whom use is not recommended (if applicable):

  • Pediatric patients under the age of 18.

Populations for whom use is contraindicated:

  • Persons known to be hypersensitive to chlorhexidine gluconate or other formula ingredients.

Age-related eligibility rules:

  • Clinical effectiveness and safety have not been established in pediatric patients under 18 years of age.

Condition-specific eligibility rules:

  • No specific restrictions are explicitly documented for hepatic or renal impairment.

Pregnancy and lactation eligibility status (if explicitly documented):

  • Pregnancy Category B; use is permitted only if clearly needed.
  • Lactation: Caution should be exercised as excretion into human milk is unknown.

Eligibility-related restrictions:

  • Use is not tested in patients with Acute Necrotizing Ulcerative Gingivitis (ANUG).
  • Exclusion is recommended for patients with certain anterior facial restorations if permanent discoloration is unacceptable.

Eligibility Classifications (High-Level)

Eligibility severity classification (as defined in official documents):

  • Contraindicated; Not Established; Conditional Use; Caution Required.

Regulatory basis (EMA / FDA / etc.):

  • FDA Prescribing Information and Health Canada Drug Register.

Eligibility-context constraints (as defined in official documents):

  • Hypersensitivity to Active Ingredient; Age; Reproductive Status; Coexisting Oral Pathology.

Resulting Eligibility Structure

Official eligibility statements:

  • Use is contraindicated in persons known to be hypersensitive to chlorhexidine gluconate or other formula ingredients.
  • The clinical effectiveness and safety have not been established in pediatric patients under the age of 18.
  • The drug should be used during pregnancy only if clearly needed (Category B).

Connection to the overall eligibility profile (2–4 sentences): Official regulatory documents strictly define eligibility based on absolute exclusion due to hypersensitivity and conditional allowance for the intended population (gingivitis). The profile is further structured by restrictions on use in pediatric groups where efficacy and safety are not established, and it mandates caution for pregnant or nursing individuals due to insufficient data on fetal or infant risk. These constraints delineate the mandatory population boundaries for the medicine's use as approved by government authorities.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information regarding Buclorhex oral rinse focuses on interactions that occur within the local oral environment, consistent with its topical formulation and negligible systemic exposure. Consequently, no systemic metabolic (CYP-mediated) or transporter-mediated interactions with other medicinal products are documented in regulatory labeling.

Local Chemical Antagonism

Interacting Substance Category Interaction Description
Anionic Agents (e.g., Sodium Lauryl Sulfate) Anionic compounds, commonly found in certain toothpastes, cause a local chemical antagonism by binding to the cationic Chlorhexidine Gluconate component. This reaction is officially documented to result in the precipitation and inactivation of Chlorhexidine, leading to a reduced antimicrobial effect on oral surfaces.
Food and Drink Eating or drinking immediately following the use of the rinse is restricted. This procedural constraint is required to maintain the local retention time and effective contact duration of the active ingredients on oral surfaces.

Administration Timing Requirements

To prevent the chemical inactivation caused by anionic agents, regulatory documents mandate a separation of administration from products containing these substances. This requirement dictates that the mouth must be thoroughly rinsed with water between brushing with an anionic toothpaste and using the Buclorhex rinse, or the rinse should be used at an entirely separate time. No population-specific interaction considerations are documented in official regulatory labeling.

Mechanism of Action

The mechanism of Buclorhex is defined by the independent actions of its two components. Chlorhexidine acts as a cationic molecule, initiating rapid electrostatic binding to the negatively charged components of microbial cell surfaces. This binding physically compromises the cell membrane integrity, resulting in the efflux of internal components and subsequent coagulation of the cytoplasm, which terminates cellular function. This action facilitates the process of localized microbial load reduction. Due to strong binding to oral tissues (substantivity), this effect is sustained over several hours. The second component, Fluoride, incorporates into the enamel's Hydroxyapatite crystal structure during remineralization to form Fluoroapatite. This modified mineral exhibits lower solubility in acidic conditions. Fluoride further acts locally to suppress bacterial metabolism by inhibiting enzymes like enolase, thereby limiting acidogenesis. The mechanisms operate synergistically: the Cationic Disruption modulates the microbial population, while the Structural Stabilization enhances the intrinsic chemical resistance of the tooth mineral. This coordinated action results in simultaneous modulation of the microbial environment and enhancement of the mineralized tissue's chemical stability.

Dosage and Administration Information

Official Administration Guidelines for Buclorhex

Buclorhex is a brand name for the prescription medication Chlorhexidine Gluconate 0.12% Oral Rinse. The instructions for proper use are defined by prescribing information and must be followed exactly.

Dosing and Administration

Guideline Official Instruction
Route of Administration Oral topical use. The solution must be expectorated (spit out) and is not for ingestion.
Standard Adult Dose 15 milliliters (mL) of the undiluted solution per dose.
Frequency Twice daily (BID), typically in the morning and evening.
Preparation Use the solution undiluted. Do not mix with water or any other liquids.

Procedural Steps and Timing

Use of the rinse is typically initiated immediately following a professional dental cleaning (prophylaxis). The specific procedural steps are:

  1. Measure the prescribed volume of the undiluted oral rinse (15 mL).
  2. Swish or rinse the solution in the mouth for 30 seconds.
  3. Spit the solution out completely; do not swallow.
  4. To ensure maximum effect, do not rinse your mouth with water, eat, or drink for at least 30 minutes after using the rinse.

If a dose is missed, continue with the next scheduled dose; do not double the dose to make up for the missed one. Safety and effectiveness in children under 18 years have not been established.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Buclorhex

This section summarizes the structure and reported observations from clinical research on the active ingredients in Buclorhex. It describes what types of studies exist, what those studies have examined, and what aspects of the medicine's use remain uncertain according to scientific literature. This information is intended to provide context about the research base, not to offer clinical advice or predictions about personal outcomes.


Studies Exploring Plaque and Gingivitis

Research has primarily explored the effects of the active ingredients, Chlorhexidine and Fluoride, in short-term Randomized Controlled Trials (RCTs) and meta-analyses related to gum health. These studies examined outcomes linked to inflammatory states, such as measuring scores for dental plaque accumulation and assessing changes in gum bleeding levels. Findings describe patterns observed in the studies regarding measurements related to plaque and gingival scores in the active groups when compared to control groups over defined short time intervals. However, findings related to the use of the combination rinse have been reported as mixed or variable when compared directly against a rinse containing only Chlorhexidine.

What remains uncertain is the durability of the measured changes over time. Long-term effects are not fully established, and data for certain groups remain insufficient, particularly for individuals with moderate or severe levels of gingival inflammation.


Studies Exploring Dental Caries

Research in this area has examined microbial outcomes, such as measuring levels of the bacteria Mutans streptococci, and has explored clinical outcomes related to the progression of decay on tooth surfaces. The available evidence on the use of Chlorhexidine mouthrinse alone for preventing decay has been reported as limited or suggests that certainty remains low regarding its outcomes. Additionally, studies focusing specifically on the additive value of the combination rinse formulation are scarce.

Therefore, the long-term effects of the combination rinse for preventing caries are not well characterized by clinical trials, and comparative evidence is lacking for certain formulations or application regimens.


Studies Exploring Post-Surgical Oral Healing

The evidence base includes systematic reviews and meta-analyses that summarize findings from multiple RCTs investigating the use of the rinse during the acute healing phase after common oral surgical procedures like tooth extraction. The studies monitored outcomes related to episodic or acute changes, such as assessing the rate of complications like alveolar osteitis (commonly known as dry socket). Reported outcomes were restricted to the immediate, short-term healing phase following the procedure. Data for certain groups remain insufficient regarding the rinse's use in advanced or specialized oral surgical fields.

Key Studies & References Delivering better oral health: an evidence-based toolkit for prevention – Chapter 9: fluoride (GOV.UK Guideline)

Frequently Asked Questions (FAQ)

Common questions about Buclorhex (FAQ)


Q: What is the duration of the effect of one dose of Buclorhex?

The active component of the rinse has a property called substantivity, which is its ability to strongly bind to oral tissues. This binding action, described in the official label, helps sustain the antibacterial effect. As a result, the localized antibacterial effect of a single dose is expected to be sustained for approximately 8 to 12 hours.


Q: Is it true that Buclorhex is only for short-term use?

In line with official safety guidance, the rinse is often licensed for a limited period of use, typically around 30 days in some regions. Prolonged use beyond the recommended duration increases the reported risk of side effects like discoloration and the formation of tartar. The duration of use is generally determined by a dental professional based on the specific oral health condition.


Q: What are the main things doctors screen for before prescribing Buclorhex?

When considering the use of this prescription rinse, health professionals primarily screen for specific contraindications and precautions. These include checking for known hypersensitivity (severe allergic reaction risk) to the ingredients. They also assess patients with anterior facial restorations where permanent discoloration may be a concern.


Q: How quickly does Buclorhex usually start to work?

The rinse's antiseptic effect begins as soon as it is used in the mouth. However, official clinical documentation indicates that it may take up to 6 weeks of consistent use to achieve the full intended benefits for treating gingivitis.


Q: Is there a generic version of Buclorhex available?

Yes, Buclorhex is a brand name for a formulation that is also available generically. According to regulatory records, the generic name for the formulation is Chlorhexidine Gluconate 0.12% Oral Rinse.


Q: Does Buclorhex interact with alcohol?

Regulatory guidance indicates that consuming alcohol is generally permitted while using this rinse. However, it is important to know that some oral rinse formulations may contain alcohol as a nonmedicinal ingredient. This is distinct from a drug-alcohol interaction.


Q: What kind of specialist usually prescribes Buclorhex?

Buclorhex is a prescription-only product that is usually prescribed by a dentist or other dental professional. This is because its primary purpose is for specialized oral health conditions requiring professional management.


Q: What should I do if Buclorhex doesn't seem to be working?

Regulatory patient instructions note that it can take up to 6 weeks of consistent use to see the full intended benefits for gingivitis. If the condition persists, or if the symptoms worsen during the treatment period, it is important to seek guidance from a doctor or dentist.


Q: Does Buclorhex have any warnings about driving or operating machinery?

There are no warnings or restrictions in the official product documents concerning the ability to drive or operate heavy machinery. This is consistent with the product being a localized oral treatment with negligible systemic absorption.


Q: Does Buclorhex treat symptoms or the underlying cause?

The official product information indicates that Buclorhex helps address both the cause and the outcome of gingivitis. The active ingredients work to reduce bacteria in the mouth while also helping to treat the visible characteristics of gingivitis, such as gum swelling, redness, and bleeding.


Q: Can Buclorhex be used long-term?

In certain regions, the official guidance for this rinse restricts use to short periods, such as 30 days. This limitation is primarily due to the increased risk of developing side effects like tooth staining and tartar buildup when the product is used for extended periods.


Q: Is Buclorhex considered a type of antibiotic?

The rinse is most often classified as an oral antiseptic and antimicrobial agent, meaning it helps control germs in the mouth. While its primary action is similar to some antimicrobials, some official therapeutic categories may also list it as an Antibiotic, Oral Rinse.


Q: Is Buclorhex known to interact with birth control pills?

According to official regulatory information, this product is used topically within the mouth and has negligible systemic (body-wide) absorption. Therefore, it is considered unlikely to affect the function of systemic medications such as hormonal contraceptives like the birth control pill.


Q: Do side effects of Buclorhex go away over time?

Common side effects, particularly temporary taste alteration, often resolve or become less noticeable over time, and usually stop completely when the product is discontinued. However, official information notes that any tooth or tongue staining that occurs may require professional dental cleaning to fully remove.


Q: Is it common to feel tired when starting Buclorhex?

Official documents containing the drug’s frequency-classified adverse reactions do not list tiredness, fatigue, or drowsiness as a common or frequent side effect for adults using the rinse as directed. This is consistent with its primary function as a local oral treatment.


Q: Does Buclorhex affect sleep?

Because the product is used topically in the mouth and has negligible absorption into the body, there are no specific reports or warnings in official documents indicating that using the rinse as directed will affect sleep or cause insomnia.


Q: Can older people typically use Buclorhex?

Official product information does not contain specific restrictions, warnings, or dosage adjustments targeted solely at the geriatric population. The only age-related restriction documented is for pediatric patients under the age of 18.


Q: Can Buclorhex cause headaches?

Headache is not listed as a frequently reported adverse reaction in the official regulatory documents for the oral rinse when it is used as directed. The documented side effects are primarily local and contained within the application site.


Q: Is Buclorhex safe for people with high blood pressure?

The rinse is a topical oral product with very little absorption into the bloodstream. Consistent with this function, official documents do not list high blood pressure or other cardiovascular conditions as a factor requiring a specific precaution or contraindication for use.


Q: Is there a risk of dependency or addiction with Buclorhex?

Official regulatory documents, which include sections on drug abuse and dependence, do not contain warnings or reports regarding the potential for dependency or addiction with this oral rinse product.


Q: Does Buclorhex affect mood or anxiety levels?

As a topical treatment with negligible systemic absorption, the rinse is not expected to affect the central nervous system. Official adverse event listings do not include effects on mood, anxiety levels, or other psychiatric conditions.


Q: Is Buclorhex safe for someone with diabetes?

Official documents do not list diabetes as a medical condition that requires a specific precaution or dosage adjustment for use of the rinse. The product is used topically and has minimal systemic effect.


Q: Does taking Buclorhex require routine lab monitoring?

The product is intended for topical use in the mouth and has negligible systemic absorption into the bloodstream. Therefore, official documentation does not indicate a need for routine blood tests or other lab monitoring while using the rinse.

How should Buclorhex be stored and disposed of?

Storage Requirements

Buclorhex oral rinse must be stored strictly according to the conditions defined in the official regulatory labeling. The product requires storage at controlled room temperature, specifically maintained between 20 C and 25 C (68 F and 77 F). It is mandatory to protect the medicine from light and it must not be frozen.

To maintain the integrity of the solution, the medicine must be kept in its original container and the bottle secured tightly closed when not in use. As a standard safety requirement, the product must always be stored out of the sight and reach of children.

Disposal Instructions

Disposal of unused or expired Buclorhex must adhere to local requirements for pharmaceutical waste. Regulatory labeling explicitly states that the medicine must not be disposed of via wastewater (such as flushing down the sink or toilet) or in regular household trash. These environmental restrictions are necessary due to the product's active ingredients.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Buclorhex found in:

A-Z Index: